SCHEMBL6173438

SCHEMBL6173438

CC(c1ccnc(N)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
ABL1 P00519 1/20 0.36
LIPE Q05469 4/20 0.35
F11 P03951 1/20 0.35
MCHR1 Q99705 6/20 0.34
CBLB Q13191 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
NPBWR1 P48145 1/20 0.34
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175578 0.88 LMNA (0.42) LMNAPOLBL3MBTL1HRH4LIPE
SCHEMBL6176756 0.88 LMNA (0.42) LMNAPOLBL3MBTL1HRH4LIPE
SCHEMBL6172084 0.86 LMNA (0.40) LMNAPOLBL3MBTL1HRH4MCHR1
SCHEMBL6175660 0.86 LMNA (0.40) LMNAPOLBL3MBTL1HRH4LIPE
SCHEMBL6171578 0.86 LMNA (0.39) LMNAPOLBL3MBTL1HRH4MCHR1
SCHEMBL6171053 0.85 LMNA (0.40) LMNAPOLBL3MBTL1HRH4LIPE
SCHEMBL6177038 0.85 LMNA (0.42) LMNAPOLBL3MBTL1MCHR1PDE2A
SCHEMBL6174848 0.85 LMNA (0.46) LMNAPOLBL3MBTL1LIPEKDM4E
SCHEMBL6171105 0.84 LMNA (0.39) LMNAPOLBL3MBTL1LIPEKDM4E
SCHEMBL6174756 0.84 MAT2A (0.43) LMNAPOLBL3MBTL1LIPEMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed